Several reports suggest that antisense oligonucleotides against miR-33 might reduce cardiovascular risk in patients by accelerating the reverse cholesterol transport pathway. However, conflicting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback